Literature DB >> 33742166

AHR in the intestinal microenvironment: safeguarding barrier function.

Brigitta Stockinger1, Kathleen Shah2, Emma Wincent3.   

Abstract

Mammalian aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that belongs to the basic helix-loop-helix (bHLH)-PAS family of transcription factors, which are evolutionarily conserved environmental sensors. In the absence of ligands, AHR resides in the cytoplasm in a complex with molecular chaperones such as HSP90, XAP2 and p23. Upon ligand binding, AHR translocates into the nuclear compartment, where it dimerizes with its partner protein, AHR nuclear translocator (ARNT), an obligatory partner for the DNA-binding and functional activity. Historically, AHR had mostly been considered as a key intermediary for the detrimental effects of environmental pollutants on the body. However, following the discovery of AHR-mediated functions in various immune cells, as well as the emergence of non-toxic 'natural' AHR ligands, this view slowly began to change, and the study of AHR-deficient mice revealed a plethora of important beneficial functions linked to AHR activation. This Review focuses on regulation of the AHR pathway and the barrier-protective roles AHR has in haematopoietic, as well as non-haematopoietic, cells within the intestinal microenvironment. It covers the nature of AHR ligands and feedback regulation of the AHR pathway, outlining the currently known physiological functions in immune, epithelial, endothelial and neuronal cells of the intestine.
© 2021. Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33742166      PMCID: PMC7611426          DOI: 10.1038/s41575-021-00430-8

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  151 in total

1.  Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine.

Authors:  Kwang Soon Kim; Sung-Wook Hong; Daehee Han; Jaeu Yi; Jisun Jung; Bo-Gie Yang; Jun Young Lee; Minji Lee; Charles D Surh
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

2.  Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization.

Authors:  A Dey; J E Jones; D W Nebert
Journal:  Biochem Pharmacol       Date:  1999-08-01       Impact factor: 5.858

3.  Aryl Hydrocarbon Receptor (AhR) Ligands as Selective AhR Modulators: Genomic Studies.

Authors:  Stephen Safe; Huajun Han; Jennifer Goldsby; Kumaravel Mohankumar; Robert S Chapkin
Journal:  Curr Opin Toxicol       Date:  2018-11-22

4.  Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation.

Authors:  Shigeyuki Uno; Timothy P Dalton; Sandrine Derkenne; Christine P Curran; Marian L Miller; Howard G Shertzer; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2004-05       Impact factor: 4.436

5.  mTOR Mediates IL-23 Induction of Neutrophil IL-17 and IL-22 Production.

Authors:  Feidi Chen; Anthony Cao; Suxia Yao; Heather L Evans-Marin; Han Liu; Wei Wu; Eric D Carlsen; Sara M Dann; Lynn Soong; Jiaren Sun; Qihong Zhao; Yingzi Cong
Journal:  J Immunol       Date:  2016-04-11       Impact factor: 5.422

6.  Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients.

Authors:  Jian Li; Andria Doty; Sarah C Glover
Journal:  Inflamm Cell Signal       Date:  2016-08-29

7.  Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo.

Authors:  João H Duarte; Paola Di Meglio; Keiji Hirota; Helena Ahlfors; Brigitta Stockinger
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

8.  Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor.

Authors:  Olga Brandstätter; Oliver Schanz; Julia Vorac; Jessica König; Tetsushi Mori; Toru Maruyama; Markus Korkowski; Thomas Haarmann-Stemmann; Dorthe von Smolinski; Joachim L Schultze; Josef Abel; Charlotte Esser; Haruko Takeyama; Heike Weighardt; Irmgard Förster
Journal:  Sci Rep       Date:  2016-05-17       Impact factor: 4.379

9.  The aryl hydrocarbon receptor controls cyclin O to promote epithelial multiciliogenesis.

Authors:  Matteo Villa; Stefania Crotta; Kevin S Dingwell; Elizabeth M A Hirst; Manolis Gialitakis; Helena Ahlfors; James C Smith; Brigitta Stockinger; Andreas Wack
Journal:  Nat Commun       Date:  2016-08-24       Impact factor: 14.919

10.  Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells.

Authors:  Elizabeth C Rosser; Christopher J M Piper; Diana E Matei; Paul A Blair; André F Rendeiro; Michael Orford; Dagmar G Alber; Thomas Krausgruber; Diego Catalan; Nigel Klein; Jessica J Manson; Ignat Drozdov; Christoph Bock; Lucy R Wedderburn; Simon Eaton; Claudia Mauri
Journal:  Cell Metab       Date:  2020-03-25       Impact factor: 27.287

View more
  19 in total

Review 1.  Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity.

Authors:  Joseph W Dean; Liang Zhou
Journal:  Trends Immunol       Date:  2022-02-05       Impact factor: 16.687

Review 2.  The gut, its microbiome, and the brain: connections and communications.

Authors:  Michael D Gershon; Kara Gross Margolis
Journal:  J Clin Invest       Date:  2021-09-15       Impact factor: 19.456

3.  The Role of Dihydroresveratrol in Enhancing the Synergistic Effect of Ligilactobacillus salivarius Li01 and Resveratrol in Ameliorating Colitis in Mice.

Authors:  Yiqiu Fei; Shuobo Zhang; Shengyi Han; Bo Qiu; Yanmeng Lu; Weixing Huang; Fang Li; Deying Chen; Björn Berglund; Hang Xiao; Lanjuan Li; Mingfei Yao
Journal:  Research (Wash D C)       Date:  2022-06-14

4.  3,3'-Diindolylmethane and 1,4-dihydroxy-2-naphthoic acid prevent chronic mild stress induced depressive-like behaviors in female mice.

Authors:  Caitlin A Madison; Jacob Kuempel; Georgia Lee Albrecht; Lauren Hillbrick; Arul Jayaraman; Stephen Safe; Robert S Chapkin; Shoshana Eitan
Journal:  J Affect Disord       Date:  2022-04-21       Impact factor: 6.533

Review 5.  Metabolic Host-Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD).

Authors:  Alexander S Dowdell; Sean P Colgan
Journal:  Pharmaceuticals (Basel)       Date:  2021-07-22

Review 6.  Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease.

Authors:  Yongyan Chen; Wenwen Cui; Xiao Li; Huan Yang
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

7.  Treatment-refractory ulcerative colitis responsive to indigo naturalis.

Authors:  Julie P Saiki; Johan Ol Andreasson; Kevin V Grimes; Lyn R Frumkin; Elvi Sanjines; Matthew G Davidson; K T Park; Berkeley Limketkai
Journal:  BMJ Open Gastroenterol       Date:  2021-12

Review 8.  Immunomodulatory drug discovery from herbal medicines: Insights from organ-specific activity and xenobiotic defenses.

Authors:  Jue Shi; Jui-Hsia Weng; Timothy J Mitchison
Journal:  Elife       Date:  2021-11-15       Impact factor: 8.140

9.  Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting.

Authors:  Matteo Puccetti; Marilena Pariano; Giorgia Renga; Ilaria Santarelli; Fiorella D'Onofrio; Marina M Bellet; Claudia Stincardini; Andrea Bartoli; Claudio Costantini; Luigina Romani; Maurizio Ricci; Stefano Giovagnoli
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

Review 10.  Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Namrata Iyer; Sinéad C Corr
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.